International Journal of Radiation Oncology * Biology * Physics
Volume 78, Issue 3 , Pages 722-728 , 1 November 2010

Brachytherapy in the Treatment of Cholangiocarcinoma

  • Eric T. Shinohara, M.D.

      Affiliations

    • Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
    • Corresponding Author InformationReprints requests to: Eric T. Shinohara, M.D., Department of Radiation Oncology, Hospital of the University of Pennsylvania, 2 Donner, 3400 Spruce Street, Philadelphia, PA 19104. Tel: (215) 662-2428; Fax: (215) 615-1658
    • ,
  • Mengye Guo, Ph.D.

      Affiliations

    • Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA
    • ,
  • Nandita Mitra, Ph.D.

      Affiliations

    • Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA
    • ,
  • James M. Metz, M.D.

      Affiliations

    • Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA

Received 3 June 2009 ,Revised 12 August 2009 ,Accepted 31 August 2009.

References 

  1. Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis. 1994;14:109–114
  2. Silva MA, Tekin K, Aytekin F, et al. Surgery for hilar cholangiocarcinoma: A 10 year experience of a tertiary referral centre in the UK. Eur J Surg Oncol. 2005;31:533–539
  3. Tan JC, Coburn NG, Baxter NN, et al. Surgical management of intrahepatic cholangiocarcinoma: A population-Based study. Ann Surg Oncol. 2008;15:600–608
  4. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463–473discussion 473–475
  5. Murakami Y, Uemura K, Hayashidani Y, et al. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma. J Surg Oncol. 2007;95:207–212
  6. Malhi H, Gores GJ. Review article: The modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol Ther. 2006;23:1287–1296
  7. Shin HS, Seong J, Kim WC, et al. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts. Int J Radiat Oncol Biol Phys. 2003;57:105–112
  8. Qian XJ, Zhai RY, Dai DK, et al. Treatment of malignant biliary obstruction by combined percutaneous transhepatic biliary drainage with local tumor treatment. World J Gastroenterol. 2006;12:331–335
  9. Kocak Z, Ozkan H, Adli M, et al. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct. Radiat Med. 2005;23:200–207
  10. Valek V, Kysela P, Kala Z, et al. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: A prospective randomised study. Eur J Radiol. 2007;62:175–179
  11. Golfieri R, Giampalma E, Fusco F, et al. Unresectable hilar cholangiocarcinoma: Multimodality treatment with percutaneous and intraluminal plus external radiotherapy. J Chemother. 2004;16(Suppl. 5):55–57
  12. Golfieri R, Giampalma E, Renzulli M, et al. Unresectable hilar cholangiocarcinoma: Multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy. In Vivo. 2006;20:757–760
  13. Andersen JR, Sorensen SM, Kruse A, et al. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut. 1989;30:1132–1135
  14. Kawamoto H, Ishii Y, Nakagawa M, et al. Analysis of longterm survivors with expandable metallic stent inserted for malignant biliary stenosis. J Hepatobiliary Pancreat Surg. 2003;10:95–100
  15. Singh V, Kapoor R, Solanki KK, et al. Endoscopic intraluminal brachytherapy and metal stent in malignant hilar biliary obstruction: A pilot study. Liver Int. 2007;27:347–352
  16. Welzel TM, McGlynn KA, Hsing AW, et al. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006;98:873–875
  17. Wong YN, Mitra N, Hudes G, et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA. 2006;296:2683–2693
  18. Rosenbaum PRRD. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41–55
  19. D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–2281
  20. Lin DY, Psaty BM, Kronmal RA. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics. 1998;54:948–963
  21. Mitra N, Heitjan DF. Sensitivity of the hazard ratio to nonignorable treatment assignment in an observational study. Stat Med. 2007;26:1398–1414
  22. Shinohara ET, Mitra N, Guo M, et al. Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2008;72:1495–1501
  23. Shinohara ET, Mitra N, Guo M, et al. Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas. Int J Radiat Oncol Biol Phys. 2009;74:1191–1198
  24. Takamura A, Saito H, Kamada T, et al. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys. 2003;57:1357–1365
  25. Alden ME, Mohiuddin M. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys. 1994;28:945–951
  26. Kamada T, Saitou H, Takamura A, et al. The role of radiotherapy in the management of extrahepatic bile duct cancer: An analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys. 1996;34:767–774
  27. Pitt HA, Nakeeb A, Abrams RA, et al. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg. 1995;221:788–797discussion 797–798
  28. Pilepich M. Hepatic and biliary cancer. New York: Marcel Dekker; 1987;
  29. Schoenthaler R, Phillips TL, Castro J, et al. Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience. Ann Surg. 1994;219:267–274
  30. Smoron GL. Radiation therapy of carcinoma of gallbladder and biliary tract. Cancer. 1977;40:1422–1424
  31. Gerhards MF, van Gulik TM, Gonzalez Gonzalez D, et al. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg. 2003;27:173–179
  32. Nelson JW, Ghafoori AP, Willett CG, et al. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2009;73:148–153
  33. Yu JB, Gross CP, Wilson LD, et al. NCI SEER public-use data: Applications and limitations in oncology research. Oncology (Williston Park). 2009;23:288–295
  34. Abrams RA. Cholangiocarcinoma—what level of evidence should we have?. Int J Radiat Oncol Biol Phys. 2009;73:1–2

 This project was funded, in part, under a grant with the Pennsylvania Department of Health. The Department specifically disclaims responsibility for any analysis, interpretations, or conclusions.

 Conflict of interest: none.

PII: S0360-3016(09)03044-2

doi: 10.1016/j.ijrobp.2009.08.070

International Journal of Radiation Oncology * Biology * Physics
Volume 78, Issue 3 , Pages 722-728 , 1 November 2010

Article Tools

* Image Usage & Resolution